Patent 9458168 was granted and assigned to Pfizer Limited on October, 2016 by the United States Patent and Trademark Office.
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia,